B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-05-08

AUTHORS

R M Saliba, S Sarantopoulos, C L Kitko, A Pawarode, S C Goldstein, J Magenau, A M Alousi, T Churay, H Justman, S Paczesny, P Reddy, D R Couriel

ABSTRACT

Biological markers for risk stratification of chronic GvHD (cGvHD) could improve the care of patients undergoing allogeneic hematopoietic stem cell transplantation. Increased plasma levels of B-cell activating factor (BAFF), chemokine (C-X-C motif) ligand 9 (CXCL9) and elafin have been associated with the diagnosis, but not with outcome in patients with cGvHD. We evaluated the association between levels of these soluble proteins, measured by ELISA at the time of cGvHD diagnosis and before the initiation of therapy, with non-relapse-mortality (NRM). Based on the log-transformed values, factor levels were divided into tertiles defined respectively as low, intermediate, and high levels. On univariable analysis, BAFF levels were significantly associated with NRM, whereas CXCL9 and elafin levels were not. Both low (⩽2.3 ng/mL, hazard ratio (HR)=5.8, P=0.03) and high (>5.7 ng/mL, HR=5.4, P=0.03) BAFF levels were associated with a significantly higher NRM compared with intermediate BAFF level. The significant effect of high or low BAFF levels persisted in multivariable analysis. A subset of cGvHD patients had persistently low BAFF levels. In conclusion, our data show that BAFF levels at the time of cGvHD diagnosis are associated with NRM, and also are potentially useful for risk stratification. These results warrant confirmation in larger studies. More... »

PAGES

1010-1015

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bmt.2017.73

DOI

http://dx.doi.org/10.1038/bmt.2017.73

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1085210535

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28481353


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Allografts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "B-Cell Activating Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chronic Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saliba", 
        "givenName": "R M", 
        "id": "sg:person.01231777347.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231777347.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cell Therapy and Hematologic Malignancies, Duke Cancer Institute, Duke University, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Division of Cell Therapy and Hematologic Malignancies, Duke Cancer Institute, Duke University, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sarantopoulos", 
        "givenName": "S", 
        "id": "sg:person.01172332715.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172332715.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA", 
          "id": "http://www.grid.ac/institutes/grid.412807.8", 
          "name": [
            "Department of Pediatrics, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kitko", 
        "givenName": "C L", 
        "id": "sg:person.0652201227.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652201227.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA", 
          "id": "http://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pawarode", 
        "givenName": "A", 
        "id": "sg:person.01105607413.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105607413.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA", 
          "id": "http://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goldstein", 
        "givenName": "S C", 
        "id": "sg:person.016115210252.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115210252.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA", 
          "id": "http://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Magenau", 
        "givenName": "J", 
        "id": "sg:person.01231243201.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231243201.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alousi", 
        "givenName": "A M", 
        "id": "sg:person.0763544234.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763544234.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA", 
          "id": "http://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Churay", 
        "givenName": "T", 
        "id": "sg:person.01251644625.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251644625.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA", 
          "id": "http://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Justman", 
        "givenName": "H", 
        "id": "sg:person.015757146255.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015757146255.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Microbiology and Immunology, Indiana University School of Medicine, Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA", 
          "id": "http://www.grid.ac/institutes/grid.257413.6", 
          "name": [
            "Department of Pediatrics, Microbiology and Immunology, Indiana University School of Medicine, Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Paczesny", 
        "givenName": "S", 
        "id": "sg:person.0707544173.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707544173.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA", 
          "id": "http://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reddy", 
        "givenName": "P", 
        "id": "sg:person.01361646751.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361646751.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Blood and Marrow Transplantation Program, Huntsman Cancer Institute, University of Utah Hospital, Salt Lake City, UT, USA", 
          "id": "http://www.grid.ac/institutes/grid.417538.c", 
          "name": [
            "Blood and Marrow Transplantation Program, Huntsman Cancer Institute, University of Utah Hospital, Salt Lake City, UT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Couriel", 
        "givenName": "D R", 
        "id": "sg:person.011456235437.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011456235437.27"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bmt.1703271", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016424594", 
          "https://doi.org/10.1038/sj.bmt.1703271"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1472-6947-13-72", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013589042", 
          "https://doi.org/10.1186/1472-6947-13-72"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri3212", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014041351", 
          "https://doi.org/10.1038/nri3212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2015.191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045947222", 
          "https://doi.org/10.1038/bmt.2015.191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar1855", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053511781", 
          "https://doi.org/10.1186/ar1855"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-05-08", 
    "datePublishedReg": "2017-05-08", 
    "description": "Biological markers for risk stratification of chronic GvHD (cGvHD) could improve the care of patients undergoing allogeneic hematopoietic stem cell transplantation. Increased plasma levels of B-cell activating factor (BAFF), chemokine (C-X-C motif) ligand 9 (CXCL9) and elafin have been associated with the diagnosis, but not with outcome in patients with cGvHD. We evaluated the association between levels of these soluble proteins, measured by ELISA at the time of cGvHD diagnosis and before the initiation of therapy, with non-relapse-mortality (NRM). Based on the log-transformed values, factor levels were divided into tertiles defined respectively as low, intermediate, and high levels. On univariable analysis, BAFF levels were significantly associated with NRM, whereas CXCL9 and elafin levels were not. Both low (\u2a7d2.3\u2009ng/mL, hazard ratio (HR)=5.8, P=0.03) and high (>5.7\u2009ng/mL, HR=5.4, P=0.03) BAFF levels were associated with a significantly higher NRM compared with intermediate BAFF level. The significant effect of high or low BAFF levels persisted in multivariable analysis. A subset of cGvHD patients had persistently low BAFF levels. In conclusion, our data show that BAFF levels at the time of cGvHD diagnosis are associated with NRM, and also are potentially useful for risk stratification. These results warrant confirmation in larger studies.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/bmt.2017.73", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2416451", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.4241938", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2482003", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "52"
      }
    ], 
    "keywords": [
      "chemokine ligand 9", 
      "low BAFF levels", 
      "BAFF levels", 
      "cell activating factor", 
      "cGVHD diagnosis", 
      "risk stratification", 
      "allogeneic hematopoietic stem cell transplantation", 
      "activating factor", 
      "non-relapse mortality", 
      "hematopoietic stem cell transplantation", 
      "chronic GVHD diagnosis", 
      "initiation of therapy", 
      "stem cell transplantation", 
      "care of patients", 
      "chronic GVHD", 
      "elafin levels", 
      "cGVHD patients", 
      "GVHD diagnosis", 
      "univariable analysis", 
      "multivariable analysis", 
      "cell transplantation", 
      "plasma levels", 
      "log-transformed values", 
      "higher NRM", 
      "factor levels", 
      "larger study", 
      "biological markers", 
      "patients", 
      "potential predictors", 
      "diagnosis", 
      "ligand 9", 
      "mortality", 
      "GVHD", 
      "cGVHD", 
      "tertile", 
      "high levels", 
      "levels", 
      "transplantation", 
      "therapy", 
      "significant effect", 
      "stratification", 
      "ELISA", 
      "elafin", 
      "care", 
      "outcomes", 
      "factors", 
      "predictors", 
      "markers", 
      "association", 
      "conclusion", 
      "confirmation", 
      "initiation", 
      "subset", 
      "time", 
      "NRM", 
      "study", 
      "protein", 
      "effect", 
      "analysis", 
      "data", 
      "soluble proteins", 
      "results", 
      "values", 
      "intermediate BAFF level"
    ], 
    "name": "B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality", 
    "pagination": "1010-1015", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1085210535"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bmt.2017.73"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28481353"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bmt.2017.73", 
      "https://app.dimensions.ai/details/publication/pub.1085210535"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:29", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_722.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/bmt.2017.73"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2017.73'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2017.73'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2017.73'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2017.73'


 

This table displays all metadata directly associated to this object as RDF triples.

304 TRIPLES      22 PREDICATES      110 URIs      97 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bmt.2017.73 schema:about N11f1871892ff438581ecafee406bfaef
2 N2dab12a2168a493eb4f9c79f8203fca0
3 N44933243394e4d5282ffad438243a0ae
4 N506b9ad994a0433c89263f21f8ac6a44
5 N5205924146dc4840a60c50b2093e5f52
6 N545942d8c3544f8abfce292848cc1501
7 Nbb63a34f0464484791b289397705d4f9
8 Nd80ccec179cf4a739708ef793198244b
9 Nda061f1c0d6f4b2c882837168f21c5d5
10 Nda5c07f2430f4343b3471a678d13e82d
11 Ne1301da00458478e9179c4453109e0f9
12 Ne4697421a1ac4d14b93ffd0ab5e8c4c5
13 Nee9b0932dd3f44e6a5927190f12a025a
14 Nfb338917e6e94e6da36a279e153c3200
15 Nfec1e1ec504844b084e09b6008bf2b45
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author N5116ddbf3c5740d9a39c32c904f019df
19 schema:citation sg:pub.10.1038/bmt.2015.191
20 sg:pub.10.1038/nri3212
21 sg:pub.10.1038/sj.bmt.1703271
22 sg:pub.10.1186/1472-6947-13-72
23 sg:pub.10.1186/ar1855
24 schema:datePublished 2017-05-08
25 schema:datePublishedReg 2017-05-08
26 schema:description Biological markers for risk stratification of chronic GvHD (cGvHD) could improve the care of patients undergoing allogeneic hematopoietic stem cell transplantation. Increased plasma levels of B-cell activating factor (BAFF), chemokine (C-X-C motif) ligand 9 (CXCL9) and elafin have been associated with the diagnosis, but not with outcome in patients with cGvHD. We evaluated the association between levels of these soluble proteins, measured by ELISA at the time of cGvHD diagnosis and before the initiation of therapy, with non-relapse-mortality (NRM). Based on the log-transformed values, factor levels were divided into tertiles defined respectively as low, intermediate, and high levels. On univariable analysis, BAFF levels were significantly associated with NRM, whereas CXCL9 and elafin levels were not. Both low (⩽2.3 ng/mL, hazard ratio (HR)=5.8, P=0.03) and high (>5.7 ng/mL, HR=5.4, P=0.03) BAFF levels were associated with a significantly higher NRM compared with intermediate BAFF level. The significant effect of high or low BAFF levels persisted in multivariable analysis. A subset of cGvHD patients had persistently low BAFF levels. In conclusion, our data show that BAFF levels at the time of cGvHD diagnosis are associated with NRM, and also are potentially useful for risk stratification. These results warrant confirmation in larger studies.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree true
30 schema:isPartOf N381e9a165d2e42038502d12b1fb2742d
31 N9d7b7a9b3a9a4fc4bf27679edef48941
32 sg:journal.1096890
33 schema:keywords BAFF levels
34 ELISA
35 GVHD
36 GVHD diagnosis
37 NRM
38 activating factor
39 allogeneic hematopoietic stem cell transplantation
40 analysis
41 association
42 biological markers
43 cGVHD
44 cGVHD diagnosis
45 cGVHD patients
46 care
47 care of patients
48 cell activating factor
49 cell transplantation
50 chemokine ligand 9
51 chronic GVHD
52 chronic GVHD diagnosis
53 conclusion
54 confirmation
55 data
56 diagnosis
57 effect
58 elafin
59 elafin levels
60 factor levels
61 factors
62 hematopoietic stem cell transplantation
63 high levels
64 higher NRM
65 initiation
66 initiation of therapy
67 intermediate BAFF level
68 larger study
69 levels
70 ligand 9
71 log-transformed values
72 low BAFF levels
73 markers
74 mortality
75 multivariable analysis
76 non-relapse mortality
77 outcomes
78 patients
79 plasma levels
80 potential predictors
81 predictors
82 protein
83 results
84 risk stratification
85 significant effect
86 soluble proteins
87 stem cell transplantation
88 stratification
89 study
90 subset
91 tertile
92 therapy
93 time
94 transplantation
95 univariable analysis
96 values
97 schema:name B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality
98 schema:pagination 1010-1015
99 schema:productId N0c876fefbbbb48b391680e9dacb965a7
100 Nddf3b4a5c5524486b77873875b42ae8c
101 Ne36bdd31b2434b1291804ea042128492
102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085210535
103 https://doi.org/10.1038/bmt.2017.73
104 schema:sdDatePublished 2021-11-01T18:29
105 schema:sdLicense https://scigraph.springernature.com/explorer/license/
106 schema:sdPublisher N3b8564c70bd34fedac857c838a20f8d3
107 schema:url https://doi.org/10.1038/bmt.2017.73
108 sgo:license sg:explorer/license/
109 sgo:sdDataset articles
110 rdf:type schema:ScholarlyArticle
111 N01d39b9ddf914d75a39b2a4e216d7636 rdf:first sg:person.0707544173.95
112 rdf:rest N65ee267fc66c4dac99ccfeee8e78bc63
113 N0c876fefbbbb48b391680e9dacb965a7 schema:name dimensions_id
114 schema:value pub.1085210535
115 rdf:type schema:PropertyValue
116 N11f1871892ff438581ecafee406bfaef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Middle Aged
118 rdf:type schema:DefinedTerm
119 N27b42dc151ab46dfba91b8e2949b6f0d rdf:first sg:person.016115210252.03
120 rdf:rest N2be14dbcdc8646438e25c84646c32940
121 N2be14dbcdc8646438e25c84646c32940 rdf:first sg:person.01231243201.65
122 rdf:rest Na5a01b20f26849a9b39412f7f921a184
123 N2dab12a2168a493eb4f9c79f8203fca0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name B-Cell Activating Factor
125 rdf:type schema:DefinedTerm
126 N381e9a165d2e42038502d12b1fb2742d schema:volumeNumber 52
127 rdf:type schema:PublicationVolume
128 N3b8564c70bd34fedac857c838a20f8d3 schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 N44933243394e4d5282ffad438243a0ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Female
132 rdf:type schema:DefinedTerm
133 N506b9ad994a0433c89263f21f8ac6a44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Disease-Free Survival
135 rdf:type schema:DefinedTerm
136 N5116ddbf3c5740d9a39c32c904f019df rdf:first sg:person.01231777347.03
137 rdf:rest Naa970d9e8a6f4e9586fea93db423eb3f
138 N5205924146dc4840a60c50b2093e5f52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Aged
140 rdf:type schema:DefinedTerm
141 N545942d8c3544f8abfce292848cc1501 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Male
143 rdf:type schema:DefinedTerm
144 N54e92df8d0af441184f74eeea5766778 rdf:first sg:person.011456235437.27
145 rdf:rest rdf:nil
146 N65ee267fc66c4dac99ccfeee8e78bc63 rdf:first sg:person.01361646751.46
147 rdf:rest N54e92df8d0af441184f74eeea5766778
148 N66b16608ac3f4cf4a8d6e8c568fb29e2 rdf:first sg:person.01105607413.87
149 rdf:rest N27b42dc151ab46dfba91b8e2949b6f0d
150 N70586a74de0140b38ab0775812809a36 rdf:first sg:person.0652201227.93
151 rdf:rest N66b16608ac3f4cf4a8d6e8c568fb29e2
152 N9d7b7a9b3a9a4fc4bf27679edef48941 schema:issueNumber 7
153 rdf:type schema:PublicationIssue
154 Na30f24314d68457ab9ba4e902b746d22 rdf:first sg:person.01251644625.47
155 rdf:rest Neddce57dec4f40b5b28c1193bf6d2163
156 Na5a01b20f26849a9b39412f7f921a184 rdf:first sg:person.0763544234.48
157 rdf:rest Na30f24314d68457ab9ba4e902b746d22
158 Naa970d9e8a6f4e9586fea93db423eb3f rdf:first sg:person.01172332715.18
159 rdf:rest N70586a74de0140b38ab0775812809a36
160 Nbb63a34f0464484791b289397705d4f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Adult
162 rdf:type schema:DefinedTerm
163 Nd80ccec179cf4a739708ef793198244b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Survival Rate
165 rdf:type schema:DefinedTerm
166 Nda061f1c0d6f4b2c882837168f21c5d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Allografts
168 rdf:type schema:DefinedTerm
169 Nda5c07f2430f4343b3471a678d13e82d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Predictive Value of Tests
171 rdf:type schema:DefinedTerm
172 Nddf3b4a5c5524486b77873875b42ae8c schema:name doi
173 schema:value 10.1038/bmt.2017.73
174 rdf:type schema:PropertyValue
175 Ne1301da00458478e9179c4453109e0f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Chronic Disease
177 rdf:type schema:DefinedTerm
178 Ne36bdd31b2434b1291804ea042128492 schema:name pubmed_id
179 schema:value 28481353
180 rdf:type schema:PropertyValue
181 Ne4697421a1ac4d14b93ffd0ab5e8c4c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Adolescent
183 rdf:type schema:DefinedTerm
184 Neddce57dec4f40b5b28c1193bf6d2163 rdf:first sg:person.015757146255.16
185 rdf:rest N01d39b9ddf914d75a39b2a4e216d7636
186 Nee9b0932dd3f44e6a5927190f12a025a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Hematopoietic Stem Cell Transplantation
188 rdf:type schema:DefinedTerm
189 Nfb338917e6e94e6da36a279e153c3200 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Humans
191 rdf:type schema:DefinedTerm
192 Nfec1e1ec504844b084e09b6008bf2b45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Graft vs Host Disease
194 rdf:type schema:DefinedTerm
195 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
196 schema:name Medical and Health Sciences
197 rdf:type schema:DefinedTerm
198 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
199 schema:name Clinical Sciences
200 rdf:type schema:DefinedTerm
201 sg:grant.2416451 http://pending.schema.org/fundedItem sg:pub.10.1038/bmt.2017.73
202 rdf:type schema:MonetaryGrant
203 sg:grant.2482003 http://pending.schema.org/fundedItem sg:pub.10.1038/bmt.2017.73
204 rdf:type schema:MonetaryGrant
205 sg:grant.4241938 http://pending.schema.org/fundedItem sg:pub.10.1038/bmt.2017.73
206 rdf:type schema:MonetaryGrant
207 sg:journal.1096890 schema:issn 0268-3369
208 1476-5365
209 schema:name Bone Marrow Transplantation
210 schema:publisher Springer Nature
211 rdf:type schema:Periodical
212 sg:person.01105607413.87 schema:affiliation grid-institutes:grid.214458.e
213 schema:familyName Pawarode
214 schema:givenName A
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105607413.87
216 rdf:type schema:Person
217 sg:person.011456235437.27 schema:affiliation grid-institutes:grid.417538.c
218 schema:familyName Couriel
219 schema:givenName D R
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011456235437.27
221 rdf:type schema:Person
222 sg:person.01172332715.18 schema:affiliation grid-institutes:grid.26009.3d
223 schema:familyName Sarantopoulos
224 schema:givenName S
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172332715.18
226 rdf:type schema:Person
227 sg:person.01231243201.65 schema:affiliation grid-institutes:grid.214458.e
228 schema:familyName Magenau
229 schema:givenName J
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231243201.65
231 rdf:type schema:Person
232 sg:person.01231777347.03 schema:affiliation grid-institutes:grid.240145.6
233 schema:familyName Saliba
234 schema:givenName R M
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231777347.03
236 rdf:type schema:Person
237 sg:person.01251644625.47 schema:affiliation grid-institutes:grid.214458.e
238 schema:familyName Churay
239 schema:givenName T
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251644625.47
241 rdf:type schema:Person
242 sg:person.01361646751.46 schema:affiliation grid-institutes:grid.214458.e
243 schema:familyName Reddy
244 schema:givenName P
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361646751.46
246 rdf:type schema:Person
247 sg:person.015757146255.16 schema:affiliation grid-institutes:grid.214458.e
248 schema:familyName Justman
249 schema:givenName H
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015757146255.16
251 rdf:type schema:Person
252 sg:person.016115210252.03 schema:affiliation grid-institutes:grid.214458.e
253 schema:familyName Goldstein
254 schema:givenName S C
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115210252.03
256 rdf:type schema:Person
257 sg:person.0652201227.93 schema:affiliation grid-institutes:grid.412807.8
258 schema:familyName Kitko
259 schema:givenName C L
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652201227.93
261 rdf:type schema:Person
262 sg:person.0707544173.95 schema:affiliation grid-institutes:grid.257413.6
263 schema:familyName Paczesny
264 schema:givenName S
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707544173.95
266 rdf:type schema:Person
267 sg:person.0763544234.48 schema:affiliation grid-institutes:grid.240145.6
268 schema:familyName Alousi
269 schema:givenName A M
270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763544234.48
271 rdf:type schema:Person
272 sg:pub.10.1038/bmt.2015.191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045947222
273 https://doi.org/10.1038/bmt.2015.191
274 rdf:type schema:CreativeWork
275 sg:pub.10.1038/nri3212 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014041351
276 https://doi.org/10.1038/nri3212
277 rdf:type schema:CreativeWork
278 sg:pub.10.1038/sj.bmt.1703271 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016424594
279 https://doi.org/10.1038/sj.bmt.1703271
280 rdf:type schema:CreativeWork
281 sg:pub.10.1186/1472-6947-13-72 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013589042
282 https://doi.org/10.1186/1472-6947-13-72
283 rdf:type schema:CreativeWork
284 sg:pub.10.1186/ar1855 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053511781
285 https://doi.org/10.1186/ar1855
286 rdf:type schema:CreativeWork
287 grid-institutes:grid.214458.e schema:alternateName Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA
288 schema:name Adult Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI, USA
289 rdf:type schema:Organization
290 grid-institutes:grid.240145.6 schema:alternateName Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
291 schema:name Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
292 rdf:type schema:Organization
293 grid-institutes:grid.257413.6 schema:alternateName Department of Pediatrics, Microbiology and Immunology, Indiana University School of Medicine, Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA
294 schema:name Department of Pediatrics, Microbiology and Immunology, Indiana University School of Medicine, Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA
295 rdf:type schema:Organization
296 grid-institutes:grid.26009.3d schema:alternateName Division of Cell Therapy and Hematologic Malignancies, Duke Cancer Institute, Duke University, Durham, NC, USA
297 schema:name Division of Cell Therapy and Hematologic Malignancies, Duke Cancer Institute, Duke University, Durham, NC, USA
298 rdf:type schema:Organization
299 grid-institutes:grid.412807.8 schema:alternateName Department of Pediatrics, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA
300 schema:name Department of Pediatrics, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA
301 rdf:type schema:Organization
302 grid-institutes:grid.417538.c schema:alternateName Blood and Marrow Transplantation Program, Huntsman Cancer Institute, University of Utah Hospital, Salt Lake City, UT, USA
303 schema:name Blood and Marrow Transplantation Program, Huntsman Cancer Institute, University of Utah Hospital, Salt Lake City, UT, USA
304 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...